BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen J, Wang Y, Yao K. Protection of retinal ganglion cells in glaucoma: Current status and future. Exp Eye Res 2021;205:108506. [PMID: 33609512 DOI: 10.1016/j.exer.2021.108506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Pérez Y, Bonet R, Corredor M, Domingo C, Moure A, Messeguer À, Bujons J, Alfonso I. Semaphorin 3A-Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration. Pharmaceuticals (Basel) 2021;14:906. [PMID: 34577606 DOI: 10.3390/ph14090906] [Reference Citation Analysis]
2 Giannaccare G, Pellegrini M, Bernabei F, Urbini L, Bergamini F, Ferro Desideri L, Bagnis A, Biagini F, Cassottana P, Del Noce C, Carnevali A, Scorcia V, Traverso CE, Vagge A. A 2-year prospective multicenter study of ultrasound cyclo plasty for glaucoma. Sci Rep 2021;11:12647. [PMID: 34135447 DOI: 10.1038/s41598-021-92233-9] [Reference Citation Analysis]
3 Sabnis RW. Novel Heterobicyclic Carboxamides for Treating Eye Diseases. ACS Med Chem Lett 2021;12:692-3. [PMID: 34055212 DOI: 10.1021/acsmedchemlett.1c00207] [Reference Citation Analysis]
4 Lambuk L, Mohd Lazaldin MA, Ahmad S, Iezhitsa I, Agarwal R, Uskoković V, Mohamud R. Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Front Pharmacol 2022;13:875662. [DOI: 10.3389/fphar.2022.875662] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sanie-Jahromi F, Mahmoudi A, Khalili MR, Nowroozzadeh MH. A Review on the Application of Stem Cell Secretome in the Protection and Regeneration of Retinal Ganglion Cells; a Clinical Prospect in the Treatment of Optic Neuropathies. Curr Eye Res 2022;:1-9. [PMID: 35876610 DOI: 10.1080/02713683.2022.2103153] [Reference Citation Analysis]
6 Vernazza S, Oddone F, Tirendi S, Bassi AM. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention. Int J Mol Sci 2021;22:7994. [PMID: 34360760 DOI: 10.3390/ijms22157994] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Somvanshi RK, Zou S, Kadhim S, Padania S, Hsu E, Kumar U. Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022;1868:166325. [DOI: 10.1016/j.bbadis.2021.166325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nutterova E, Fus M, Bartosova L, Klimesova I, Lestak J. Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost. JCM 2022;11:4159. [DOI: 10.3390/jcm11144159] [Reference Citation Analysis]
9 Porciatti V, Chou TH. Modeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies. Cells 2021;10:1398. [PMID: 34198840 DOI: 10.3390/cells10061398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]